Giuseppe Spadaro
Overview
Explore the profile of Giuseppe Spadaro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
2408
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pulvirenti F, Milito C, Cinetto F, Garzi G, Sardella G, Spadaro G, et al.
J Allergy Clin Immunol Glob
. 2025 Jan;
4(1):100384.
PMID: 39867744
Background: Many patients with X-linked agammaglobulinemia (XLA) nowadays have reached adulthood, as well as their sisters, possibly carriers of a deleterious Bruton tyrosine kinase variant. Studies on motherhood outcomes in...
2.
Di Bona D, Bilancia M, Crimi C, Daddato M, Benfante A, Caiaffa M, et al.
Clin Exp Allergy
. 2024 Oct;
55(2):202-204.
PMID: 39390847
This study identifies two distinct subgroups of patients with severe eosinophilic asthma who respond differently to mepolizumab. Cluster analysis reveals that patients with a family history of asthma, positive skin...
3.
Carlea A, Angelino A, Mazzarelli L, Maria Maruotti G, Fulgione C, Orlandi G, et al.
Eur J Obstet Gynecol Reprod Biol
. 2024 Sep;
302:388-390.
PMID: 39245602
No abstract available.
4.
Poto R, Cristinziano L, Criscuolo G, Strisciuglio C, Palestra F, Lagnese G, et al.
Front Immunol
. 2024 Aug;
15:1443704.
PMID: 39188724
Introduction: The Janus kinase (JAK) family includes four cytoplasmic tyrosine kinases (JAK1, JAK2, JAK3, and TYK2) constitutively bound to several cytokine receptors. JAKs phosphorylate downstream signal transducers and activators of...
5.
Ferrara A, Palestra F, Piscitelli F, Petraroli A, Suffritti C, Firinu D, et al.
Allergy
. 2024 Jun;
80(1):287-296.
PMID: 38935036
Background: Hereditary angioedema (HAE) is a rare genetic disorder characterized by local, self-limiting edema due to temporary increase in vascular permeability. HAE with normal C1 esterase inhibitor (C1INH) activity includes...
6.
Pelaia C, Crimi C, Benfante A, Caiaffa M, Campisi R, Candia C, et al.
Respirology
. 2024 Jun;
29(10):869-879.
PMID: 38847185
Background And Objective: Several randomized controlled trials (RCTs) have shown that benralizumab is characterized by a good profile of efficacy and safety, thereby being potentially able to elicit clinical remission...
7.
Mormile I, Gigliotti M, Ferrara A, Gatti R, Spadaro G, De Paulis A, et al.
Immunol Res
. 2024 Jun;
72(5):991-1002.
PMID: 38829492
Idiopathic non-histaminergic acquired angioedema (InH-AAE) is a rare disease, with unknown etiology and pathogenesis, characterized by recurrent clinical manifestations and resistance to antihistamines and corticosteroids. We aim to evaluate clinical...
8.
Cane L, Poto R, Palestra F, Iacobucci I, Pirozzi M, Parashuraman S, et al.
Int J Mol Sci
. 2024 Apr;
25(7).
PMID: 38612858
Thymic stromal lymphopoietin (TSLP), mainly expressed by epithelial cells, plays a central role in asthma. In humans, TSLP exists in two variants: the long form TSLP (lfTSLP) and a shorter...
9.
Villa A, Milito C, Deiana C, Gambier R, Punziano A, Buso H, et al.
J Clin Immunol
. 2024 Feb;
44(2):59.
PMID: 38319477
The long-term effects of SARS-CoV-2 infection represent a relevant global health problem. Long COVID (LC) is defined as a complex of signs and symptoms developed during or after SARS-CoV-2 infection...
10.
DOnofrio M, La Prova D, Galdiero M, Cantone E, Tremante E, Mascolo M, et al.
J Clin Med
. 2023 Nov;
12(22).
PMID: 38002582
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, systemic necrotizing vasculitis affecting small-to-medium-sized vessels. EGPA's clinical manifestations are heterogeneous, affecting different organs and systems, and the upper respiratory tract can...